Intelligent Health AI Conference September 2020 - FarmaTrust
summary
FarmaTrust presents a distributed ledger supply‑chain platform that claims needle-to-needle transparency for cell and gene therapies, is authorised under FMD and ran FDA pilots, and lists partners including McKesson and NHS institutions. Platform is mobile-first, records immutable hashes, consolidates siloed data, and enables recalls down to packet/item level in 15-second recall demonstrations. Also offers randomized-label clinical‑trial tracking, predictive dashboards for demand and logistics, and a patent‑pending BLT for personalized medicine.
AI-written summary · about
chapters (6)
- 0:00Start
- 1:25Three Main Verticals
- 3:36Problems in Supply Chain
- 4:55Benefits of DLT Solution
- 6:48Mobile First Approach
- 8:20De-risking Distributed Ledger Tech
related talks
30mTrust, a Key Factor in Deploying AI in Healthcare
25mThe Ethical Introduction of AI in Clinical Practice: Is There Such a Thing?
45mEstablishing Trust in AI: Blockchain
25mMedtech Champions Made in Germany
12mBuilding trust in AI: Insights from MDIA at AIBC Euro-Med
22mAI & Blockchain: New solutions that actually work
12mTrace3’s Evolution in Healthcare Solutions: Stability and Innovation
20mHow AI & Blockchain are revolutionizing the Health and Wellness sector